JPWO2020194046A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020194046A5 JPWO2020194046A5 JP2021556883A JP2021556883A JPWO2020194046A5 JP WO2020194046 A5 JPWO2020194046 A5 JP WO2020194046A5 JP 2021556883 A JP2021556883 A JP 2021556883A JP 2021556883 A JP2021556883 A JP 2021556883A JP WO2020194046 A5 JPWO2020194046 A5 JP WO2020194046A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- dose
- metformin
- sitagliptin
- glimepiride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962823575P | 2019-03-25 | 2019-03-25 | |
| US62/823,575 | 2019-03-25 | ||
| PCT/IB2020/000141 WO2020194046A1 (en) | 2019-03-25 | 2020-03-25 | Low-dose triple combination formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022529312A JP2022529312A (ja) | 2022-06-21 |
| JPWO2020194046A5 true JPWO2020194046A5 (ko) | 2023-04-05 |
Family
ID=72611638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556883A Pending JP2022529312A (ja) | 2019-03-25 | 2020-03-25 | 低用量の三重複合製剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220184070A1 (ko) |
| EP (1) | EP3946343A4 (ko) |
| JP (1) | JP2022529312A (ko) |
| KR (1) | KR20220004026A (ko) |
| CN (1) | CN113905738A (ko) |
| AU (1) | AU2020245801A1 (ko) |
| BR (1) | BR112021018973A2 (ko) |
| CA (1) | CA3134799A1 (ko) |
| MX (1) | MX2021011745A (ko) |
| TW (1) | TW202102208A (ko) |
| WO (1) | WO2020194046A1 (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230310462A1 (en) * | 2020-09-02 | 2023-10-05 | Laboratorios Silanes S.A. De C.V. | Combination drug for the control and management of type 2 diabetes mellitus |
| CN113559088A (zh) * | 2021-01-21 | 2021-10-29 | 江苏宇锐医药科技有限公司 | 一种含二甲双胍和西格列汀的复方降糖药物制剂 |
| WO2024043358A1 (ko) * | 2022-08-24 | 2024-02-29 | 동아에스티 주식회사 | 에보글립틴 및 메트포르민을 포함하는 경구용 복합제제 및 그의 제조방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS60438B1 (sr) * | 2009-02-13 | 2020-07-31 | Boehringer Ingelheim Int | Farmaceutska kompozicija koja sadrži sglt2 inhibitor, dpp-iv inhibitor i opciono drugo antidijabetičko sredstvo i njihove upotrebe |
| US20160151382A1 (en) * | 2013-10-08 | 2016-06-02 | Kevin Ray Pickering | Cooperative Medication Combination Systems |
| WO2016040462A2 (en) * | 2014-09-09 | 2016-03-17 | ARKAY Therapeutics, LLC | Formulations and methods for treatment of metabolic syndrome |
| KR20180002460A (ko) * | 2016-06-29 | 2018-01-08 | 주식회사 엘지화학 | 제2형 당뇨병 및 당뇨성 이상지질혈증 치료용 조성물, 키트 및 병용 요법 |
-
2020
- 2020-03-25 CA CA3134799A patent/CA3134799A1/en active Pending
- 2020-03-25 CN CN202080039014.8A patent/CN113905738A/zh active Pending
- 2020-03-25 WO PCT/IB2020/000141 patent/WO2020194046A1/en unknown
- 2020-03-25 US US17/598,122 patent/US20220184070A1/en active Pending
- 2020-03-25 EP EP20777507.3A patent/EP3946343A4/en active Pending
- 2020-03-25 AU AU2020245801A patent/AU2020245801A1/en active Pending
- 2020-03-25 JP JP2021556883A patent/JP2022529312A/ja active Pending
- 2020-03-25 MX MX2021011745A patent/MX2021011745A/es unknown
- 2020-03-25 BR BR112021018973A patent/BR112021018973A2/pt unknown
- 2020-03-25 KR KR1020217033516A patent/KR20220004026A/ko unknown
- 2020-03-25 TW TW109110097A patent/TW202102208A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100643833B1 (ko) | 인슐린 감작제 및 다른 항당뇨병 약제의 개선된 방출을위한 제약 조성물 | |
| US6677358B1 (en) | NIDDM regimen | |
| TWI280125B (en) | Pharmaceutical compositions for treating type 2 diabetes in drug naive human patients | |
| ES2302702T3 (es) | Composicion farmaceutica que comprende una combinacion de metformina y glibenclamida. | |
| JP6066144B2 (ja) | 併用医薬 | |
| JP2005516919A (ja) | 抗糖尿病製剤および方法 | |
| KR20220157486A (ko) | 2-[(4-(6-[(4-시아노-2-플루오로벤질)옥시]피리딘-2-일)피페리딘-1-일)메틸]-1-[(2s)-옥세탄-2-일메틸]-1h-벤즈이미다졸-6-카르복실산 또는 그의 제약상 염을 사용한 제2형 당뇨병 또는 비만 또는 과체중의 치료 | |
| US6461639B2 (en) | Core formulation | |
| TWI519297B (zh) | 使用雙醋瑞因之糖尿病輔助療法 | |
| KR20090107262A (ko) | 미티글리나이드 및 메트포르민 복합제제 및 그의 제조방법 | |
| Davis | Oral hypoglycaemic drugs for the treatment of type 2 diabetes mellitus | |
| JPWO2020194046A5 (ko) | ||
| JP2024515137A (ja) | Ｇｐｒ４０アゴニスト及びｓｇｌｔ－２阻害剤を含む医薬組成物 | |
| CN101897697A (zh) | 降糖药物组合物及用途 | |
| KR101380813B1 (ko) | 2형 당뇨병 치료용 병용 의약 | |
| JP2002529430A (ja) | ベータ−アゴニストおよび他の抗糖尿病薬を含む組合せ | |
| RU2021130019A (ru) | Состав низкодозовой тройной комбинации | |
| ES2444265T3 (es) | Composiciones farmacéuticas para el tratamiento de la diabetes mellitus | |
| JPWO2020194052A5 (ko) | ||
| US20080015229A1 (en) | Use of rimonabant for the preparation of medicaments useful in the prevention and treatment of type 2 diabetes | |
| US20040176457A1 (en) | Novel NIDDM regimen | |
| US20110015270A1 (en) | Novel NIDDM Regimen | |
| CN116999398A (zh) | 一种口服组合物 | |
| WO2022089133A1 (zh) | 一种降低血糖的组合、应用和方法 | |
| RU2021130142A (ru) | Низкодозовый тройной комбинированный состав |